Metraipolis › archive › dc_adad2276cf13

Optimizing glucocorticoid therapy in congenital adrenal hyperplasia and analog conditions: the intersection of dose reduction, patient care, and coverage in… — Europe PMC PMID:40995600

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40995600
DOI
10.3389/fendo.2025.1603701
License (as archived)
solo-consultazione
Archived
2026-11-10T01:35:48.025Z
SHA-256 of the archived text
0c7c72a4b64415339902225a7abc9f69d3c9cdc65a4c6431d927a7f216a4b619
Stable URL of this page
https://metraipolis.com/documento/dc_adad2276cf13

How to cite

Optimizing glucocorticoid therapy in congenital adrenal hyperplasia and analog conditions: the intersection of dose reduction, patient care, and coverage in… — Europe PMC PMID:40995600 — Europe PMC (en), https://europepmc.org/article/MED/40995600 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_adad2276cf13 (Metraipolis archive dc_adad2276cf13, sha256 0c7c72a4b64415339902225a7abc9f69d3c9cdc65a4c6431d927a7f216a4b619)
BibTeX
@misc{dcadad2276cf13,
  title = {Optimizing glucocorticoid therapy in congenital adrenal hyperplasia and analog conditions: the intersection of dose reduction, patient care, and coverage in… — Europe PMC PMID:40995600},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40995600},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_adad2276cf13; sha256 0c7c72a4b64415339902225a7abc9f69d3c9cdc65a4c6431d927a7f216a4b619},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40995600. Agents can read the archived copy with the MCP tool read_document.